Showing results (1-10 of 30) with videos related to
Sort By:
Pageof 3
Biotechnology Progress|June 3, 2006
Control of culture environment for improved polyethylenimine-mediated transient production of recombinant monoclonal antibodies by CHO cellsDouglas J Galbraith, Andrew S Tait, Andrew J Racher, et al.Biochemical and Biophysical Research Communications|June 25, 2003
Evaluation of individual protein errors in silver-stained two-dimensional gelsC Mark Smales, John R Birch, Andrew J Racher, et al.Biotechnology Progress|May 21, 2005
On the optimal ratio of heavy to light chain genes for efficient recombinant antibody production by CHO cellsStefan Schlatter, Scott H Stansfield, Diane M Dinnis, et al.Proteomics|October 26, 2005
Proteomic analysis of enriched microsomal fractions from GS-NS0 murine myeloma cells with varying secreted recombinant monoclonal antibody productivitiesDaniel E Alete, Andrew J Racher, John R Birch, et al.Biotechnology and Bioengineering|November 23, 2006
Dynamic analysis of GS-NS0 cells producing a recombinant monoclonal antibody during fed-batch cultureScott H Stansfield, Emma E Allen, Diane M Dinnis, et al.Biochimica Et Biophysica Acta|June 30, 2006
On the statistical analysis of the GS-NS0 cell proteome: imputation, clustering and variability testingNorhaiza Ahmad, Jian Zhang, Phillip J Brown, et al.Biotechnology and Bioengineering|February 21, 2006
Functional proteomic analysis of GS-NS0 murine myeloma cell lines with varying recombinant monoclonal antibody production rateDiane M Dinnis, Scott H Stansfield, Stefan Schlatter, et al.Biotechnology and Bioengineering|May 22, 2019
Improving the accuracy of flux balance analysis through the implementation of carbon availability constraints for intracellular reactionsMaximilian Lularevic, Andrew J Racher, Colin Jaques, et al.Biotechnology Progress|July 13, 2010
Strategies for selecting recombinant CHO cell lines for cGMP manufacturing: realizing the potential in bioreactorsAlison J Porter, Alan J Dickson, Andrew J RacherPageof 3